FDI Clinical Research – San Juan
About This Site
Fundación de Investigación–San Juan (FDI Clinical Research) provides patients in San Juan, Puerto Rico with access to clinical trials focused on advancing new and innovative treatment options. Founded in 2002, the site brings over 20 years of experience serving the local community and is dedicated to supporting patients through every step of the research process. FDI Clinical Research conducts studies across multiple therapeutic areas, including fatty liver disease (MASH/MASLD), cirrhosis, nephropathy, psoriatic arthritis, and obesity, among others.
Our experienced team creates a welcoming, patient-centered environment where your safety, comfort, and privacy are always the top priority. By partnering with leading pharmaceutical and biotechnology companies, we offer clinical trials across a wide range of health conditions—bringing cutting-edge research opportunities closer to home.
Conditions at this location
Select a condition to learn more about it.
-
Atherosclerotic Cardiovascular Disease (ASCVD)
Atherosclerotic cardiovascular disease happens when plaque builds up inside the arteries and limits blood flow. This can raise the risk of heart attack, stroke, and other heart-related health problems.
- Fatty Liver Disease
- Nonalcoholic Steatohepatitis (NASH)
-
Influenza Vaccine
Flu vaccines help protect against seasonal influenza and its complications. Researchers continue to study new vaccine options that may offer broader or longer-lasting protection.
-
Healthy Volunteer
Healthy volunteer studies include people who do not have the condition being studied. Their participation helps researchers learn more about the safety, dosing, and effects of potential treatments.
-
Obesity
Obesity is a long-term health condition involving excess body fat. It can raise the risk of other health concerns, and research is exploring new ways to support weight and overall health.
- Weight Loss for Obesity
-
Type 2 Diabetes
Type 2 diabetes affects how the body uses insulin and manages blood sugar. Ongoing care can help control blood sugar and lower the risk of serious health problems.
-
Type 2 Diabetes and Obesity
Type 2 diabetes and obesity are closely connected and can affect heart and overall health. Researchers are studying treatments that may support both blood sugar and weight management.
-
Type 2 Diabetes with Heart Disease
Living with both type 2 diabetes and heart disease can increase the risk of heart-related complications. Researchers are studying new treatments to help people manage both conditions.
Providers at this location
-
Mirelis Acosta-Rivera
M.D.
Mirelis Acosta-Rivera M.D.
Dr. Mirelis Acosta-Rivera is a Board-Certified Oncologist, subspecializing in Hematology with 9 years of research experience as a Primary Investigator. Dr. Acosta-Rivera is a published physician with extensive Oncology data management experience, currently holds position as the Chief Medical Officer of the FDI site, and is an active advocate for the ethnic/rural populations in Puerto Rico. Dr. Acosta-Rivera has remained an active investigator and participant in over 28 varying research trials. Among the numerous trial indications, she has led trials for top Sponsors, in all trial phases. Ranging through Metastatic Head and Neck cancer, Metastatic Urothelial Cancer, Myelodysplastic Syndromes, Colorectal Cancer, Chronic Pain related to Cancer, Non-Hodgkin’s Lymphoma, Lung Cancer, among several other indications, Dr. Acosta-Rivera proves to be an expert within her specialty. -
Alexandra Montalvo Acevedo
M.D.
Alexandra Montalvo Acevedo M.D.
Dr. Alexandra Montalvo-Acevedo is a triple Board-Certified Psychiatry, Neurology, and Pediatrics physician. Coming in to the FDI site, Dr. Montalvo’s pediatric practices throughout the island’s communities have followed her. Being a published physician, bilingual in Spanish and English, and avid presenter, Dr. Montalvo’s profile dexterity maintains the site’s scope for research opportunities at a broader scale, specifically within trial indications for CNS and Pediatrics. Early research work extends from Congenital Zika Virus to Cognitive Activities, Aging, and Mild Cognitive Impairment. -
Grisell Ortiz-Lasanta
M.D.
Grisell Ortiz-Lasanta M.D.
Dr. Grisell Ortiz-Lasanta is a Board-Certified Internal Medicine physician with 24+ years of clinical experience. Since starting her research career in 2007, Dr. Ortiz-Lasanta has completed extensive research and publications for Hepatic studies and other indications. As a bilingual physician, she offers the ability to treat a well-versed population of patients from different ethnic backgrounds. Knowledgeable in her specialty, Dr. Ortiz-Lasanta has been successful in educating our Puerto Rico communities of research benefits and new medicinal advances, allowing the FDI site to create better relationships within the surrounding communities, and has aided in building a more profound internal patient database. -
Cristina Ramos-Romey
M.D.
Crisitina J. Ramos-Romey M.D.
Dr. Cristina Ramos-Romey is a Board-certified Geriatric Medicine and Allergy & Immunology physician, subspecializing in Internal Medicine. As a published physician she has invested time in over 19 publications for her own research in Immunology and similar specialties. With over 24 years of Clinical experience, 9 years of Research experience, and fluent in both Spanish and English, Dr. Ramos-Romey renders herself as a well seasoned PI, allowing her to treat a well versed population of patients from different ethnic backgrounds, and better educate our Puerto Rico communities of research benefits and new medicinal advances. Dr. Ramos-Romey has conducted research ranging through indications such as Urticaria, Asthma, Dysberic Osteonecrosis, and more. -
Oscar Ruiz-Bermudez
M.D.
Oscar L. Ruiz-Bermudez M.D.
Dr. Oscar Ruiz-Bermudez is a Board-Certified Endocrinologist who has led and participated in studies of all phases and indications. Located in Puerto Rico, Dr Ruiz-Bermudez’s independent clinical research site carries an almost exclusively Hispanic specific population. Knowledgeable in his specialty and bilingual in Spanish and English, Dr. Ruiz-Bermudez has been successful in educating our Puerto Rico communities of research benefits and new medicinal advances, allowing the FDI site to create better relationships within the surrounding communities, and has aided in building a more profound internal patient database. Within Dr. Ruiz-Bermudez’s clinical trial participation he has specifically participated in trials varying through indications such as Hypertension, DPNP, Diabetes, Acute Coronary Syndromes, Dyslipidemia, among other indications.
Ready to be part of healthcare history? Find the right clinical trial for you.
